Avinash Amin - 15 Jun 2026 Form 4 Insider Report for Neuronetics, Inc. (STIM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jun 2026, 16:57:02 UTC
Prior SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Avinash Amin

Key filing fact

Avinash Amin filed Form 4 for Neuronetics, Inc. (STIM) on 17 Jun 2026.

Key facts

  • This page summarizes Avinash Amin's Form 4 filing for Neuronetics, Inc. (STIM).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2026, 16:57.

Change

  • Previous filing in this sequence was filed on 29 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002044406 Primary reporting owner

Amin Avinash

Relationship
Director
Address
C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN
Signature
/s/ Avinash Amin
Signature date
17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STIM transaction

Common Stock

Other

Transaction value
Shares
-2,934
Change %
-4%
Price
$0.000000*
Shares after
69,566
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1, F2
STIM transaction

Common Stock

Other

Transaction value
Shares
-34,932
Change %
-50%
Price
$0.000000*
Shares after
34,634
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1, F3
STIM transaction

Common Stock

Other

Transaction value
Shares
-4,634
Change %
-13%
Price
$0.000000*
Shares after
30,000
Date
15 Jun 2026
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration.

Footnote F2

Represents shares of common stock transferred to Health Partners.

Footnote F3

Represents shares of common stock transferred to Cayman Master.

Footnote F4

Represents shares of common stock transferred to Select Opportunities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .